ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,434,000 | -81.1% | 104,521 | -74.7% | 0.01% | -78.9% |
Q3 2021 | $12,869,000 | -11.3% | 412,466 | 0.0% | 0.06% | -10.9% |
Q2 2021 | $14,511,000 | -0.2% | 412,466 | 0.0% | 0.06% | +1.6% |
Q1 2021 | $14,539,000 | -6.0% | 412,466 | 0.0% | 0.06% | +8.6% |
Q4 2020 | $15,472,000 | -15.6% | 412,466 | -24.9% | 0.06% | -20.5% |
Q3 2020 | $18,322,000 | +87.4% | 549,047 | +48.8% | 0.07% | +69.8% |
Q2 2020 | $9,776,000 | +61.8% | 369,047 | 0.0% | 0.04% | +16.2% |
Q1 2020 | $6,041,000 | -4.9% | 369,047 | +47.6% | 0.04% | +8.8% |
Q4 2019 | $6,355,000 | +27.1% | 250,000 | 0.0% | 0.03% | 0.0% |
Q3 2019 | $5,000,000 | -38.0% | 250,000 | 0.0% | 0.03% | -38.2% |
Q2 2019 | $8,060,000 | +0.1% | 250,000 | 0.0% | 0.06% | +5.8% |
Q1 2019 | $8,053,000 | +31.3% | 250,000 | 0.0% | 0.05% | +4.0% |
Q4 2018 | $6,133,000 | -25.6% | 250,000 | 0.0% | 0.05% | -7.4% |
Q3 2018 | $8,240,000 | -7.2% | 250,000 | 0.0% | 0.05% | -19.4% |
Q2 2018 | $8,875,000 | +9.0% | 250,000 | 0.0% | 0.07% | -2.9% |
Q1 2018 | $8,143,000 | +59.0% | 250,000 | +25.0% | 0.07% | +56.8% |
Q4 2017 | $5,120,000 | +22.2% | 200,000 | 0.0% | 0.04% | +29.4% |
Q3 2017 | $4,190,000 | +1.7% | 200,000 | 0.0% | 0.03% | -5.6% |
Q2 2017 | $4,120,000 | – | 200,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $744 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |